These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16286529

  • 1. High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes.
    Tajiri Y, Mimura K, Umeda F.
    Obes Res; 2005 Oct; 13(10):1810-6. PubMed ID: 16286529
    [Abstract] [Full Text] [Related]

  • 2. Retinopathy and hypertension affect serum high-sensitivity C-reactive protein levels in Type 2 diabetic patients.
    Tsunoda K, Arita M, Yukawa M, Ueyama M, Furuta M, Nakagawa T, Nanjo K, Sanke T.
    J Diabetes Complications; 2005 Oct; 19(3):123-7. PubMed ID: 15866055
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 5. Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (Val-Mets).
    Shishido T, Konta T, Nishiyama S, Miyashita T, Miyamoto T, Takasaki S, Nitobe J, Watanabe T, Takeishi Y, Kubota I.
    Clin Exp Hypertens; 2011 Dec 20; 33(2):117-23. PubMed ID: 21269062
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
    Aso Y, Wakabayashi S, Nakano T, Yamamoto R, Takebayashi K, Inukai T.
    Metabolism; 2006 Aug 20; 55(8):1014-21. PubMed ID: 16839835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.
    Ryu SY, Kim KS, Park J, Kang MG, Han MA.
    J Prev Med Public Health; 2008 Nov 20; 41(6):413-8. PubMed ID: 19037171
    [Abstract] [Full Text] [Related]

  • 10. Meal testing and postprandial state of type 2 diabetic patients with metabolic syndrome.
    Brădescu OM, Georgescu M, Ifrim S, Ioacără S, Ionescu-Tîrgovişte C.
    Rom J Intern Med; 2005 Nov 20; 43(1-2):97-113. PubMed ID: 16739870
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis.
    Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M.
    Exp Clin Endocrinol Diabetes; 2004 Jul 20; 112(7):378-82. PubMed ID: 15239023
    [Abstract] [Full Text] [Related]

  • 13. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
    Ahmad J, Ahmned F, Siddiqui MA, Khan AR, Katyal P, Hameed B, Ahmad I.
    J Assoc Physicians India; 2007 Oct 20; 55():693-9. PubMed ID: 18173021
    [Abstract] [Full Text] [Related]

  • 14. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J.
    J Hypertens; 2008 Nov 20; 26(11):2168-75. PubMed ID: 18854757
    [Abstract] [Full Text] [Related]

  • 15. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis.
    Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, Sugita Y, Yamauchi-Takihara K.
    Clin Chim Acta; 2007 Sep 20; 384(1-2):99-104. PubMed ID: 17618612
    [Abstract] [Full Text] [Related]

  • 16. Further inflammatory information on metabolic syndrome by adiponectin evaluation.
    Matsushita K, Tamakoshi K, Yatsuya H, Wada K, Otsuka R, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H.
    Int J Cardiol; 2008 Mar 14; 124(3):339-44. PubMed ID: 17433469
    [Abstract] [Full Text] [Related]

  • 17. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    Alizadeh Dehnavi R, Beishuizen ED, van de Ree MA, Le Cessie S, Huisman MV, Kluft C, Princen HM, Tamsma JT.
    Eur J Intern Med; 2008 Mar 14; 19(2):115-21. PubMed ID: 18249307
    [Abstract] [Full Text] [Related]

  • 18. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R, Puri A, Makhija A, Singhal A, Ahuja A, Mukerjee S, Dwivedi SK, Narain VS, Saran RK, Puri VK.
    Indian Heart J; 2008 Mar 14; 60(3):205-9. PubMed ID: 19240308
    [Abstract] [Full Text] [Related]

  • 19. Effects of lifestyle modifications on C-reactive protein: contribution of weight loss and improved aerobic capacity.
    Jae SY, Fernhall B, Heffernan KS, Jeong M, Chun EM, Sung J, Lee SH, Lim YJ, Park WH.
    Metabolism; 2006 Jun 14; 55(6):825-31. PubMed ID: 16713444
    [Abstract] [Full Text] [Related]

  • 20. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
    Int J Obes (Lond); 2007 Feb 14; 31(2):213-20. PubMed ID: 16755284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.